tiprankstipranks
Trending News
More News >
Catalyst Pharma (CPRX)
NASDAQ:CPRX
US Market
Advertisement

Catalyst Pharma (CPRX) Technical Analysis

Compare
2,376 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Catalyst Pharma’s (CPRX) Moving Averages Convergence Divergence (MACD) indicator is -0.29, suggesting Catalyst Pharma is a Sell.
Catalyst Pharma’s (CPRX) 20-Day exponential moving average is 20.56, while Catalyst Pharma’s (CPRX) share price is $20.19, making it a Sell.
Catalyst Pharma’s (CPRX) 50-Day exponential moving average is 21.27, while Catalyst Pharma’s (CPRX) share price is $20.19, making it a Sell.

Catalyst Pharma (CPRX) Pivot Points

Aug 29, 2025, 06:34 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
18.70
19.27
19.60
20.17
20.50
21.07
21.40
Fibonacci
19.27
19.61
19.82
20.17
20.51
20.72
21.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Catalyst Pharma (CPRX) Moving Averages

Aug 29, 2025, 06:34 PM
Period
Simple
Exponential
MA5
20.48Sell
20.32Sell
MA10
20.35Sell
20.39Sell
MA20
20.57Sell
20.56Sell
MA50
21.14Sell
21.27Sell
MA100
22.48Sell
21.87Sell
MA200
22.40Sell
21.79Sell
Catalyst Pharma’s (CPRX) 10-Day exponential moving average is 20.39, while Catalyst Pharma’s (CPRX) share price is $20.19, making it a Sell.
Catalyst Pharma’s (CPRX) 100-Day exponential moving average is 21.87, while Catalyst Pharma’s (CPRX) share price is $20.19, making it a Sell.
Catalyst Pharma’s (CPRX) stock price is $20.19 and Catalyst Pharma’s (CPRX) 50-day simple moving average is 21.14, creating a Sell signal.
Catalyst Pharma’s (CPRX) stock price is $20.19 and Catalyst Pharma’s (CPRX) 100-day simple moving average is 22.48, creating a Sell signal.
Catalyst Pharma’s (CPRX) stock price is $20.19 and Catalyst Pharma’s (CPRX) 200-day simple moving average is 22.40, creating a Sell signal.

Catalyst Pharma (CPRX) Technical Indicators

Aug 29, 2025, 06:34 PM
Name
Value
Implied Action
RSI (14)
44.07
Neutral
STOCH (9,6)
21.40
Neutral
STOCHRSI (14)
35.63
Neutral
MACD (12,26)
-0.29
Sell
ADX (14)
17.71
Buy
Williams %R
-66.22
Buy
CCI (14)
-52.15
Neutral
ATR (14)
0.69
-
Ultimate Oscillator
36.91
Neutral
ROC
2.80
Buy
Catalyst Pharma’s (CPRX) Relative Strength Index (RSI) is 44.07, creating a Neutral signal.
Catalyst Pharma’s (CPRX) Trend Strength Indicator (ADX) is 17.71, creating a Buy signal.
Catalyst Pharma’s (CPRX) Commodity Channel Index (CCI) is -52.15, creating a Neutral signal.
Catalyst Pharma’s (CPRX) Price Rate of Change (ROC) is 2.80, creating a Buy signal.

FAQ

Is CPRX a Buy, Hold, or Sell?
Based on CPRX’s technical indicators, CPRX is a Strong Sell.
    What is CPRX’s RSI (14)?
    CPRX’s RSI (14) is 44.07, which suggests CPRX is a Neutral.
      What is CPRX’s MACD?
      CPRX’s MACD is -0.29, which suggests CPRX is a Sell.
        What is CPRX’s 5-day moving average?
        CPRX’s 5-day moving average is 20.48, which suggests CPRX is a Sell.
          What is CPRX’s 20-day moving average?
          CPRX 20-day moving average is 20.57, which suggests CPRX is a Sell.
            What is CPRX’s 50-day moving average?
            CPRX’s 50-day moving average is 21.14, which suggests CPRX is a Sell.
              What is CPRX’s 200-day moving average?
              CPRX’s 200-day moving average is 22.40, which suggests CPRX is a Sell.
                What is CPRX’s Williams % R (14)?
                CPRX’s Williams % R (14) is -66.22, which suggests CPRX is a Buy.
                  What is CPRX’s CCI (14)?
                  CPRX’s CCI (14) is -52.15, which suggests CPRX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis